ArticleBMC gastroenterology2026
Predicting clinical outcomes in Helicobacter pylori-positive patients using supervised learning through the integration of demographic and genomic features.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of Resistance-AssociatedAntibiotics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHelicobacter pylori (H. pylori) infection is widespread globally and is linked to outcomes ranging from chronic gastritis to gastric cancer. However, only a minority of infected individuals progress to malignancy, influenced by a mix of bacterial, host, and environmental factors. Current predictive approaches are limited due to relying mainly on clinical and lifestyle data. Genomic approaches have been sparsely used, and thus their incorporation into machine learning models could ensure early and personalized detection. This study aimed to evaluate the impact of integrating host metadata with genomic features from H. pylori to predict gastric cancer outcomes and identify associated variables.
methodsOne thousand three hundred sixty-three publicly available H. pylori genomes with associated host information between 1991 and 2024 were collected from NCBI and EnteroBase. Demographic features, virulence genes, sequence-derived and variant-based features were extracted. Machine learning models were then developed to classify infection outcomes into gastric cancer and non-gastric cancer and trained using internal cross-validation folds within the training set comprising 80% of the dataset. Logistic regression, an interpretable baseline model, was compared against higher-performance ensemble models (XGBoost, Random Forest). Final model performance was assessed on the held-out test set using recall, precision, AUROC, and AUPRC curves.
resultsThe logistic regression model achieved a recall of 0.737 (95% CI: 0.637–0.830) for gastric cancer and an AUROC of 0.830 (95% CI: 0.779–0.880). Both XGBoost and Random Forest models outperformed the baseline model with AUROC values ranging from 0.950 to 0.954 (95% CI: 0.904–0.976). Black-box model recall for gastric cancer detection improved compared to the baseline by 8.14% for XGBoost (0.797, 95% CI: 0.711–0.877), and 11.3% for Random Forest (0.820, 95% CI: 0.734–0.896). Across models, patient age consistently emerged as the strongest predictor of gastric cancer, with several sequence-derived genomic features beyond pre-established virulence genes contributing to the infection outcome differences.
conclusionThis study demonstrates that combining pathogen genomics with host demographics uncovers novel risk factors and ensures early detection with high predictive power. The use of explainability methods like SHAP allows for greater interpretability by clinical professionals and improves informed decision-making processes. While internal validation showed strong performance, external validation on independent data and translation into clinical practice is necessary using broader, diverse datasets, along with the inclusion of additional host and lifestyle variables.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.